NextPlat's ClearMetrx Subsidiary to Launch Artificial Intelligence-Powered ClearMetrX 4.0 Software for Modernized Healthcare Analytics and Reporting
Rhea-AI Summary
NextPlat (NASDAQ: NXPL) has announced the development of ClearMetrX 4.0, an AI-enhanced healthcare data analytics and reporting software. The platform, set to be rolled out internally in Q4 2025 with commercial deployment in H1 2026, will integrate advanced AI capabilities to improve healthcare operations efficiency and patient outcomes.
The software will feature AI-powered functionalities including revenue forecasting, predictive inventory management, anomaly detection, audit assistance, fraud detection, and what-if simulations. This development aligns with the growing AI healthcare market, which is projected to reach $187.69 billion by 2030, with a CAGR of 38.62% from 2025 to 2030.
Positive
- Entry into the rapidly growing AI healthcare market projected to reach $187.69B by 2030
- Enhanced revenue forecasting and inventory management capabilities through AI integration
- Expanded service offering with fraud detection and compliance reporting features
- Building upon existing successful ClearMetrX platform with proven market acceptance
Negative
- Delayed commercial deployment until first half of 2026
- Potential implementation and adoption challenges in healthcare settings
- Competition in the growing AI healthcare analytics market
News Market Reaction
On the day this news was published, NXPL declined 11.61%, reflecting a significant negative market reaction. Argus tracked a peak move of +15.1% during that session. Argus tracked a trough of -27.0% from its starting point during tracking. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $3M from the company's valuation, bringing the market cap to $23M at that time. Trading volume was exceptionally heavy at 15.8x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Enhanced Software Suite to Feature AI-Assisted Analytics and Insights Designed to Support Greater Efficiency in Healthcare Operations While Driving Improved Patient Adherence and Outcomes
ClearMetrX is a cloud-based, end-to-end reporting platform that streamlines data analytics for physicians, management services organizations (MSOs), 340B entities, and pharmacies, and is actively used across the Company's pharmacies and client network. ClearMetrX 4.0 will integrate an array of AI-powered enhancements into the software, designed to increase its value as a comprehensive decision-support system, enabling a more streamlined way to collect, analyze and operationalize organizational healthcare data. According to Grandview Research, the global AI in healthcare market size was estimated at
Birute Norkute, Vice President of Healthcare Operations at NextPlat, said, "Since its introduction, ClearMetrX has demonstrated its capabilities to positively impact not only the business of healthcare for us and a growing list of customers, but importantly, support better outcomes through improved patient adherence. With ClearMetrX 4.0, we are honoring our commitment to harness the power of technology such as AI to further improve the efficiency and effectiveness of healthcare to the benefit of all stakeholders."
Highlighted features of ClearMetrX 4.0 include:
- Revenue Forecasting: Utilizing AI/ML models to predict revenue, prescription volumes, and patient demand with accuracy.
- Predictive Inventory Management: Intelligent AI forecasting to optimize stock levels and reduce shortages or waste.
- Anomaly & Exception Detection: Real-time AI tools to spot abnormal prescribing, dispensing, or claims patterns.
- Audit Assistance, Analytics & Reporting: AI-powered dashboards that automate evidence gathering, compliance reporting, and deliver actionable analytics.
- Fraud Detection: Advanced AI analytics to identify suspicious billing or dispensing activity.
- What-If Simulations: AI-driven scenario models to evaluate financial and compliance outcomes.
To learn more about ClearMetrX or to request information on how it can meet your needs or to schedule a demonstration, please visit https://www.clearmetrx.com/
For more information about NextPlat, please visit www.NextPlat.com and connect with us on Facebook, LinkedIn and X.
About NextPlat Corp
Nextplat is a global consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide. Through acquisitions, joint ventures, and collaborations, the Company seeks to assist businesses in selling their goods online, domestically, and internationally, allowing customers and partners to optimize their e-Commerce presence and revenue. NextPlat currently operates an e-Commerce communications division offering voice, data, tracking, and IoT products and services worldwide as well as pharmacy and healthcare data management services in
Forward-Looking Statements
Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company's business and any of its products, services or solutions. The words "believe," "forecast," "project," "intend," "expect," "plan," "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, including the Company's ability to launch additional e-commerce capabilities for consumer and healthcare products and its ability to grow and expand as intended, any of which could cause the Company to not achieve some or all of its goals or the Company's previously reported actual results, performance (finance or operating), including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), copies of which may be obtained from the SEC's website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.
Media and Investor Contact for NextPlat Corp:
Michael Glickman
MWGCO, Inc.
917-397-2272
mike@mwgco.net
View original content to download multimedia:https://www.prnewswire.com/news-releases/nextplats-clearmetrx-subsidiary-to-launch-artificial-intelligence-powered-clearmetrx-4-0-software-for-modernized-healthcare-analytics-and-reporting-302563941.html
SOURCE NextPlat Corp.
FAQ
When will NextPlat (NXPL) launch ClearMetrX 4.0?
What are the main features of NextPlat's ClearMetrX 4.0 software?
How large is the AI healthcare market that NextPlat is entering?
Who are the target customers for NextPlat's ClearMetrX 4.0?
What problems does NextPlat's ClearMetrX 4.0 solve?
